FDA grants emergency use of Novavax COVID-19 vaccine
Unlike Moderna's and Pfizer-BioNTech's mRNA vaccine, Novavax's vaccine was created using a trace amount of the COVID spike protein, resulting in immune response from the human body, which is boosted by another substance.